Novel Drug Combinations for Gastric Cancer
Phase 2
240
about 4.7 years
18+
11 sites in CA, LA, MI +2
What this study is about
This trial is testing new drug combinations to treat gastric cancer. The treatment involves taking several different medications, and it will last about 1700 days. Participants will be adults.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 5-Fluorouracil
- 2.Take AZD0901
- 3.Take AZD7789
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluorouracil (Antimetabolite; mimics uracil to disrupt DNA/RNA in cancer cells), capecitabine, chemotherapy
oral (Oral Tablet), infusion
Primary: ORR (per RECIST 1.1 as assessed by Investigator)
Secondary: DoR per RECIST 1.1 based on Investigator assessment., OS, PFS per RECIST 1.1 as assessed by the Investigator